American International Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,664
| Closed | -$309K | – | 1421 |
|
|
2024
Q1 | $309K | Buy |
15,664
+69
| +0.4% | +$1.36K | ﹤0.01% | 1901 |
|
|
2023
Q4 | $274K | Sell |
15,595
-63
| -0.4% | -$1.11K | ﹤0.01% | 2005 |
|
|
2023
Q3 | $272K | Buy |
15,658
+557
| +4% | +$9.68K | ﹤0.01% | 1952 |
|
|
2023
Q2 | $213K | Buy |
15,101
+66
| +0.4% | +$929 | ﹤0.01% | 2123 |
|
|
2023
Q1 | $162K | Buy |
15,035
+299
| +2% | +$3.22K | ﹤0.01% | 2231 |
|
|
2022
Q4 | $221K | Sell |
14,736
-54
| -0.4% | -$809 | ﹤0.01% | 2086 |
|
|
2022
Q3 | $190K | Buy |
14,790
+209
| +1% | +$2.69K | ﹤0.01% | 2183 |
|
|
2022
Q2 | $141K | Buy |
14,581
+102
| +0.7% | +$986 | ﹤0.01% | 2394 |
|
|
2022
Q1 | $144K | Sell |
14,479
-1,020
| -7% | -$10.1K | ﹤0.01% | 2432 |
|
|
2021
Q4 | $182K | Sell |
15,499
-463
| -3% | -$5.44K | ﹤0.01% | 2429 |
|
|
2021
Q3 | $182K | Sell |
15,962
-379
| -2% | -$4.32K | ﹤0.01% | 2485 |
|
|
2021
Q2 | $228 | Buy |
16,341
+761
| +5% | +$11 | ﹤0.01% | 2426 |
|
|
2021
Q1 | $288 | Buy |
15,580
+40
| +0.3% | +$1 | ﹤0.01% | 2158 |
|
|
2020
Q4 | $275 | Sell |
15,540
-444
| -3% | -$8 | ﹤0.01% | 2100 |
|
|
2020
Q3 | $245K | Buy |
15,984
+4,355
| +37% | +$66.8K | ﹤0.01% | 2013 |
|
|
2020
Q2 | $296K | Buy |
11,629
+3,370
| +41% | +$85.8K | ﹤0.01% | 1883 |
|
|
2020
Q1 | $128K | Sell |
8,259
-478
| -5% | -$7.41K | ﹤0.01% | 2167 |
|
|
2019
Q4 | $97K | Sell |
8,737
-73
| -0.8% | -$810 | ﹤0.01% | 2641 |
|
|
2019
Q3 | $75K | Sell |
8,810
-61
| -0.7% | -$519 | ﹤0.01% | 2745 |
|
|
2019
Q2 | $120K | Buy |
8,871
+1,311
| +17% | +$17.7K | ﹤0.01% | 2568 |
|
|
2019
Q1 | $137K | Buy |
7,560
+3,288
| +77% | +$59.6K | ﹤0.01% | 2430 |
|
|
2018
Q4 | $120K | Sell |
4,272
-32
| -0.7% | -$899 | ﹤0.01% | 2499 |
|
|
2018
Q3 | $110K | Buy |
+4,304
| New | +$110K | ﹤0.01% | 2783 |
|